Healthtech and edtech are two of the fastest growing sectors, with the healthtech market size to reach $3.1 billion by 2033, while the global education technology market size is projected to reach $348.41 billion by 2030.
Each week will do a roundup of the top news, fundings, and IPOs from these two sectors.
Top News
- Collage AI acquired StudyWise, an Israeli startup that developed an AI platform for exam and assignment management in education. StudyWise, which has operated without external funding since its 2024 founding, will become the global development hub for Collage AI’s educational technology
- Hologic, which sells diagnostic imaging systems, molecular diagnostic tests and surgical treatment devices for women’s health, announced it plans to be sold to asset management firms Blackstone and TPG for up to $18.3 billion. The definitive agreement calls for the two firms to acquire Hologic for $79 per share. A transaction would result in the women’s health medtech company becoming privately held. The deal is expected to close in the first half of 2026
AI News
- Triomics, an oncology-focused generative AI company, partnered with Memorial Sloan Kettering Cancer Center’s iHub and Clinical Research Innovation Consortium programs to deploy Triomics’ AI-powered clinical-trial matching and screening system in MSK active clinical trials
- Albert Invent, a digital platform for materials science research and development, partnered with Kenvue, maker of consumer health products like Zyrtec, Neutrogena, and Listerine, to accelerate end-to-end R&D efforts across the company’s global portfolio of brands
- Penguin Ai, a healthcare artificial intelligence company, partnered with UPMC Enterprises, the innovation and commercialization arm of healthcare provider and insurer UPMC, to accelerate the advancement of AI models specifically designed for the healthcare industry
Late Stage Fundings:
Healthtech:
- Electra Therapeutics, a late-stage US biotechnology company developing treatments for immune-mediated diseases and cancer, raised a $183 million Series C round co-led by EQT Life Sciences and Nextech, with participation from new investors Sanofi, HBM Healthcare Investments, and Mubadala Capital, alongside all existing investors
Early Stage Fundings
Healthtech:
- Petal Surgical, a company developing a new field of incisionless surgery via a distinct form of histotripsy using robotics and AI, raised a $10 million Series A funding round led by K50 and TSVC, with participation from Draper’s, ShangBay Capital, Eliot Horowitz, Dr. Frederic H. Moll and others
- roclub, a teleoperation platform for medical technology, raised $11.7 million in a Series A round led by Smedvig Ventures and YZR, with participation from existing investor Speedinvest and angel investors
- Cala Health, a bioelectronic medicine company transforming the standard of care for chronic disease, raised $50 million from Niterra Ventures
- NewLimit, a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells, raised $45 million from Eli Lilly and Company, Duke Management Co, Section 32, Kleiner Perkins, Dimension, Abstract, Human Capital, and Boost
- Unlimited Bio, a biotechnology company developing combinatorial therapies to address the multi-system nature of aging, raised an undisclosed amount of funding from Immortal Dragons
- PleoPharma, a company focused on finding treatments for cannabis-related health issues, raised a $36 million Series B financing round from undisclosed investors
- Felix Health, a provider of on-demand everyday healthcare in Canada, raised $53 million in financing led by existing investor Canadian Business Growth Fund, with participation from Business Development Bank of Canada’s Women in Tech Venture Fund, BMO Capital Partners, Whitecap Venture Partners and H Venture Partners with support from Scotiabank
- knownwell, a provider of obesity medicine and weight-inclusive primary care, raised $25 million in a round led by CVS Health Ventures, with participation from MassMutual Catalyst Fund, Intermountain Ventures, and others, along with continued support from existing investors a16z Bio + Health and Flare Capital Partners
- Faeth Therapeutics, a clinical-stage biotechnology company advancing therapies that systematically target tumor metabolism, raised a $25 million round led by S2G Investments with participation from existing investors Khosla Ventures, Future Ventures, Digitalis Ventures, KdT Ventures and Cantos, plus new investors B Capital Group, Avicella and THO Seed Fund
- Sage Care, a platform designed to eliminate healthcare navigation inefficiencies through a combination of clinically intelligent AI agents and advanced optimization algorithms, raised $20 million in funding led by Yosemite and continued support from General Catalyst, Metrodora, OVTR.VC, SV Angel, Liquid 2, Seven Stars, Refract Ventures, AME Cloud Ventures, and Apollo Ono
- Catalyst OrthoScience, a medical technology company redefining shoulder arthroplasty, raised $15 million in equity and debt financing, led by RC Capital, with participation from Mutual Capital Partners, Dr. Derace Schaffer, and Western Alliance Bank, Member FDIC
- VerAvanti, a developer of single use intravascular endoscopic technologies, raised a $5 million strategic investment from a Middle Eastern family office that operates a premier regional medical device distributor
- Exeliom Biosciences, a clinical-stage biotechnology company developing new therapies in immuno-oncology and immuno-inflammation, raised a $3.31 million extension to its Series A round led by existing investors Biocodex with participation by Crescent Ventures, UI Investissement and Forepont Capital Partners
Edtech:
- Knack, a student success technology platform that enables higher education institutions to power and scale peer learning programs, raised a Series B funding round led by New Markets Venture Partners
- Magma Math, an AI-powered K-12 instructional platform empowering teachers and creating student-centered classrooms, raised a $10 million funding round from current investor Five Elms Capital
Seed Fundings
Healthtech:
- Valink Therapeutics, a biotechnology company developing next-generation oncology therapeutics with a focus on bispecific antibody-drug conjugates and complementary modalities for improved patient outcomes, raised a $11.8 million funding round led by redalpine, with participation from new investors LongeVC and Oxford Science Enterprises. Existing investors, including RV Invest, p53 Invest, and Hoxton Ventures also contributed to the round
- Generation Lab, a company measuring molecular disbalance, a marker of aging, using a straightforward cheek-swab test combined with patented methodologies, raised an $11 million seed funding round led by Accel, along with Samsung Next, Zone2, EDM legend Steve Aoki’s Aoki Labs, Build Your Legacy Ventures, and Markham Valley Ventures
- Ampa, a neurotechnology company using breakthroughs in neuroscience to create practical tools that help people recover their mental health, raised an $8.5 million round led by Nexus NeuroTech Ventures, along with Satori Capital, Morningside Ventures, Continuum Health Ventures, and the Zabara Foundation, alongside new and existing individual investors
- Fourier Health, a clinician-in-the-loop AI platform that streamlines and consolidates patient clinical data into use-case specific summaries to reduce administrative burden, raised $8.4 million in seed funding led by Yosemite, with participation from Innospark Ventures, NextGen Venture Partners and Tau Ventures, and pre-seed funding from Lasagna, NextGen Venture Partners, Myelin, and Despierta
- VitVio, an AI-powered platform that autonomously coordinates operating room staff, flags delays, and reduces the administrative load on surgical teams, raised an $8 million seed led by returning investor Bek Ventures with participation from LDV Capital and Tiny Supercomputer Investment Company, as well as new investors Balnord, Thornapple River Capital, Joe Mullings, and Mati Staniszewski
- Andel, a platform giving employers an affordable way to include GLP-1s and other brand name medications, raised a $4.5 million round from Lightbank, Seedcamp, Bertelsmann Healthcare Investments, Houghton Street Ventures, and Springboard
- Vega Health, a healthcare technology company focused on enabling health systems to realize measurable value from artificial intelligence, raised $4 million in seed funding from Bessemer Venture Partners
- Newton, an AI-powered dental workflow automation platform, raised $3.8 million in seed funding from Y Combinator, Twenty Two Ventures, The Transpose Platform, Phosphor Capital, David Parker, Bo Jiang, and other angel investors
Fund News
- India Quotient closed on $129 million for its fifth fund to invest in information technology, healthcare, financial services, media, software-as-a-service, artificial intelligence, beauty, gaming, HR tech, B2C, mobile, edtech, foodtech, adtech, and supply chain tech based in the Indian region
- Spex Capital secured €30 million in commitments for its new Venture HealthTech Fund, which is targeting €100 million. The fund will invest in early-stage healthtech startups, with investments of up to €5 million. It plans to scale breakthrough startups through its partnerships with health organisations including the National Health Service in the UK, Penn Medicine – a multi-hospital health system servicing seven million patients in the US – and EIT Digital, the European platform focused on digital innovation and entrepreneurship
- Calm/Storm Ventures, based in Vienna, launched a €30 million fund aimed at early-stage healthtech startups
Policy and government
- Seven of the nine universities that the White House initially approached about a plan to steer more federal money toward schools aligned with President Trump’s priorities have refused to endorse the proposal. Only one, the University of Texas, suggested it might be open to signing on quickly. The University of Arizona rejected the Trump administration’s compact, joining Brown University, Dartmouth College, M.I.T., the University of Pennsylvania, the University of Southern California and the University of Virginia. Vanderbilt University did not directly express a view about the plan — the deadline the Trump administration initially gave universities for feedback — but its chancellor suggested misgivings about parts of it
- The Trump administration announced that drugmaker EMD Serono will lower the price of one of its leading fertility drugs as part of a push to make in vitro fertilization more affordable. The company’s drug GONAL-F, which helps stimulate ovulation, will soon be available at a discount through TrumpRx, a federal website expected to launch in 2026
Random news
- Participants who completed game-like activities through BrainHQ, an online subscription program, showed increased production of acetylcholine, sometimes called the “pay attention” chemical. The process that produces acetylcholine in the brain is called the cholinergic system. Researchers at McGill University in Montreal led a clinical trial of 92 people ages 65 and older. All were healthy, meaning they had not been diagnosed with a cognitive disorder. In the study, called Improving Neurological Health in Aging via Neuroplasticity-based Computerized Exercise, participants were randomly split into two groups of 46. Both groups were asked to spend 30 minutes a day doing an assigned activity on a computer or mobile device for 10 weeks. People in the intervention group did BrainHQ exercises, while those in the control group played games designed for entertainment. People in the BrainHQ group had a 2.3% increase in acetylcholine production in the anterior cingulate cortex, and the research claims to be the first of its kind to show that brain training exercises can offset natural decline in cholinergic function
(Image source: prismic.io)
